CG Asset Management’s Eli Lilly LLY Stock Holding History

CG Asset Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-4,089	Closed	-$294K	–	124
2016 Q1	$294K	Sell	4,089 -9,515	-70%	-$720K	0.12%	103
2015 Q4	$1.15M	Sell	13,604 -2,595	-16%	-$215K	0.46%	62
2015 Q3	$1.36M	Buy	+16,199	New	+$1.37M	0.57%	57

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CG Asset Management's LLY Position: Q2 2016 in Review

CG Asset Management sold out of Eli Lilly (LLY) in Q2 2016, closing a stake of 4,089 shares — an estimated $294K sold.

CG Asset Management first reported a position in LLY in Q3 2015 and held it in 3 quarters. The position peaked at $1.36M in Q3 2015. 1,179 funds tracked by Wall St. Rank hold LLY as of Q2 2016.

CG Asset Management reported no remaining Eli Lilly position as of Q2 2016 after selling out during the quarter.
CG Asset Management sold 4,089 Eli Lilly shares in Q2 2016, an estimated $294K.
CG Asset Management first reported a position in Eli Lilly in Q3 2015 and held it in 3 quarters.
CG Asset Management's Eli Lilly position peaked at $1.36M in Q3 2015.
1,179 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2016.

Based on CG Asset Management's 13F filing for Q2 2016, filed 27 Jul 2016.